Budesonide/Carmoterol Hydrochloride

N/A

Report date: 2025/11/27 15:17:26

Base Information

Drug NameBudesonide/Carmoterol Hydrochloride
Drug Alias NameCarmoterol and BudesonideBudesonide and carmoterolBudesonide/CarmoterolCHF-5188
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonistsBeta-2 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptorGlucocorticoid receptor
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsYes Carmoterol HydrochlorideBudesonide
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesChiesi Farmaceutici SPA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChiesi Farmaceutici SPA
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A